JP Morgan 2018 Archives -

England is at the forefront of the genomics revolution – but NHS patients are unlikely to be the first to benefit.

A world leader in genomics, but England’s patients face obstacles to tests

https://pharmaphorum.com/views-analysis-patients/world-leader-genomics-englands-patients-face-obstacles-tests/

Axovant misreports trial results, Lundbeck Alzheimer’s drug fails

Bad week for dementia R&D after Axovant howler and another failed trial

https://pharmaphorum.com/news/bad-week-dementia-rd-axovant-howler-another-failed-trial/

Walmsley has axed 40% of management team in shake-up

A Pfizer consumer buyout won’t detract from pharma business, says GSK chief

https://pharmaphorum.com/news/gsk-looking-pfizer-consumer-health-unit-ceo/

Johnson & Johnson’s CEO Alex Gorsky says he would welcome the disruptive influence of Amazon should it decide

Health firms should prepare for Amazon move, says J&J chief

https://pharmaphorum.com/news/jjs-ceo-gorsky/

JP Morgan 2018